Stocksigma LogoStocksigma Logo

Smruthi Organics Receives ANVISA Inspection Report for Unit II API Facility

Smruthi Organics received an inspection report from the Brazilian Health Regulatory Agency (ANVISA) for its Unit II facility in Solapur, Maharashtra

Smruthi Organics Receives ANVISA Inspection Report for Unit II API Facility

Smruthi Organics Ltd 路 Others (Uncategorized) 路 21 Oct 2026, 5:02 pm

Smruthi Organics Receives ANVISA Inspection Report for Unit II API Facility Smruthi Organics received an inspection report from the Brazilian Health Regulatory Agency (ANVISA) for its Unit II facility in Solapur, Maharashtra, following an audit conducted from 7th Jun'26 to 11th Jun'26. The facility was classified as "Complies with Good Manufacturing Practices with Corrective Action" and fulfills conditions for certification regarding the inspected active pharmaceutical ingredient (API). While final GMP certification remains pending receipt, the outcome marks a critical regulatory milestone toward securing market clearance in Brazil.

Original exchange filing (PDF)

More announcements from Smruthi Organics Ltd

All Smruthi Organics Ltd announcements